The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Larina V.N.

N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia

Oynotkinova O.Sh.

Research Institute of Health Organization and Medical Management;
Central State Medical Academy of the Office of the President of the Russian Federation

Larin V.G.

Pirogov Russian National Research Medical University

Lunev V.I.

Pirogov Russian National Research Medical University

Matskeplishvili S.T.

Lomonosov Moscow State University

Gusarenko S.A.

Branch of the Main Directorate for Servicing the Diplomatic Corps under the Ministry of Foreign Affairs of Russia “Medical Center”

Heart failure with preserved left ventricular ejection fraction: a comprehensive phenotype-based approach to diagnosis and treatment

Authors:

Larina V.N., Oynotkinova O.Sh., Larin V.G., Lunev V.I., Matskeplishvili S.T., Gusarenko S.A.

More about the authors

Read: 8531 times


To cite this article:

Larina VN, Oynotkinova OSh, Larin VG, Lunev VI, Matskeplishvili ST, Gusarenko SA. Heart failure with preserved left ventricular ejection fraction: a comprehensive phenotype-based approach to diagnosis and treatment. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(6):627‑636. (In Russ.)
https://doi.org/10.17116/kardio202215061627

Recommended articles:
Virus-associated progesterone-resistant chro­nic endo­metritis — the onco­risk situation?. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):25-30
Modern approaches to cystic lung diseases diagnosis. Journal of Respiratory Medi­cine. 2025;(1):30-37
Primary bile acid synthesis diso­rders. Russian Journal of Evidence-Based Gastroenterology. 2025;(1):71-90
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73

References:

  1. Cho D, Yoo B. Current Prevalence, Incidence, and Outcomes of Heart Failure with Preserved Ejection Fraction. Heart Fail Clin. 2021;17(3):315-326.  https://doi.org/10.1016/j.hfc.2021.03.002
  2. Yancy C, Lopatin M, Stevenson L, De Marco T, Fonarow G. Clinical Presentation, Management, and In-Hospital Outcomes of Patients Admitted With Acute Decompensated Heart Failure With Preserved Systolic Function. J Am Coll Cardiol. 2006;47(1):76-84.  https://doi.org/10.1016/j.jacc.2005.09.022
  3. Powell-Wiley T, Ngwa J, Kebede S, Lu D, Schulte P, Bhatt D., et al. Impact of Body Mass Index on Heart Failure by Race/Ethnicity From the Get With The Guidelines — Heart Failure (GWTG—HF) Registry. JACC: Heart Failure. 2018;6(3):233-242.  https://doi.org/10.1016/j.jchf.2017.11.011
  4. Crespo‐Leiro M, Anker S, Maggioni A, Coats A, Filippatos G, Ruschitzka F, et al. European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions. Eur J Heart Fail. 2016;18(6):613-625.  https://doi.org/10.1002/ejhf.566
  5. Dunlay S, Roger V, Redfield M. Epidemiology of heart failure with preserved ejection fraction. Nature Reviews Cardiology. 2017;14(10):591-602.  https://doi.org/10.1038/nrcardio.2017.65
  6. Fomin I. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Journal of Cardiology. 2016;(8):7-13. (In Russ.). https://doi.org/10.15829/1560-4071-2016-8-7-13
  7. Gavryushina SV, Ageev FT. Heart failure with preserved left ventricular ejection fraction: epidemiology, patient «portrait», clinic and diagnostics. Kardiologiia. 2018;58(S4):55-64. (In Russ.). https://doi.org/10.18087/cardio.2467
  8. Oshchepkova EV, Lazareva NV, Satlykova DF, Tereshchenko SN. The First Results of the Russian Register of Chronic Heart Failure. Kardiologiia. 2015;5:22-28. (In Russ.). https://doi.org/10.18565/cardio.2015.5.22-28
  9. Vasyuk YuA, Shupenina EYu, Namazova GA, Dubrovskaya TI. Novel algorithms for diagnosing heart failure with preserved ejection fraction in patients with hypertension and obesity. Cardiovascular Therapy and Prevention. 2021;20(1):65-69. (In Russ.). https://doi.org/10.15829/1728-8800-2021-2569
  10. van Riet E, Hoes A, Wagenaar K, Limburg A, Landman M, Rutten F. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016;18(3):242-252.  https://doi.org/10.1002/ejhf.483
  11. Brouwers F, de Boer R, van der Harst P, Voors A, Gansevoort R, Bakker S., et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34(19):1424-1431. https://doi.org/10.1093/eurheartj/eht066
  12. Silverman M, Patel B, Blankstein R, Lima J, Blumenthal R, Nasir K. et al. Impact of Race, Ethnicity, and Multimodality Biomarkers on the Incidence of New-Onset Heart Failure With Preserved Ejection Fraction (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2016;117(9):1474-1481. https://doi.org/10.1016/j.amjcard.2016.02.017
  13. Ho J, Lyass A, Lee D, Vasan R, Kannel W, Larson M., et al. Predictors of New-Onset Heart Failure. Circulation: Heart Failure. 2013;6(2):279-286.  https://doi.org/10.1161/circheartfailure.112.972828
  14. Gerber Y, Weston S, Redfield M, Chamberlain A, Manemann S, Jiang R, et al. A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015;175(6):996.  https://doi.org/10.1001/jamainternmed.2015.0924
  15. Tsao C, Lyass A, Enserro D, Larson M, Ho J, Kizer J, et al. Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction. JACC: Heart Failure. 2018;6(8):678-685.  https://doi.org/10.1016/j.jchf.2018.03.006
  16. Seferović P, Petrie M, Filippatos G, Anker S, Rosano G, Bauersachs J., et al. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(5):853-872.  https://doi.org/10.1002/ejhf.1170
  17. Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2016;18(8):891-975.  https://doi.org/10.1002/ejhf.592
  18. Loop M, Van Dyke M, Chen L, Brown T, Durant R, Safford M., et al. Comparison of Length of Stay, 30-Day Mortality, and 30-Day Readmission Rates in Medicare Patients With Heart Failure and With Reduced Versus Preserved Ejection Fraction. Am J Cardiol. 2016;118(1):79-85.  https://doi.org/10.1016/j.amjcard.2016.04.015
  19. Lam C, Voors A, de Boer R, Solomon S, van Veldhuisen D. Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J. 2018;39(30):2780-2792. https://doi.org/10.1093/eurheartj/ehy301
  20. Paulus W, Tschöpe C, Sanderson J, Rusconi C, Flachskampf F, Rademakers F, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28(20):2539-2550. https://doi.org/10.1093/eurheartj/ehm037
  21. Pagel P, Tawil J, Boettcher B, Izquierdo D, Lazicki T, Crystal G, et al. Heart Failure With Preserved Ejection Fraction: A Comprehensive Review and Update of Diagnosis, Pathophysiology, Treatment, and Perioperative Implications. J Cardiothorac Vasc Anesth. 2021;35(6):1839-1859. https://doi.org/10.1053/j.jvca.2020.07.016
  22. Verbrugge F, Omote K, Reddy Y, Sorimachi H, Obokata M, Borlaug B. Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality. Eur Heart J. 2022. doi:10.1093/eurheartj/ehab911.
  23. Reddy Y, Obokata M, Gersh B, Borlaug B. High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea. Circulation. 2018;137(5):534-535.  https://doi.org/10.1161/circulationaha.117.030093
  24. Reddy Y, Carter R, Obokata M, Redfield M, Borlaug B. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation. 2018;138(9):861-870.  https://doi.org/10.1161/circulationaha.118.034646
  25. Heart Failure with Preserved Ejection Fraction. New England Journal of Medicine. 2017;376(9):896-897.  https://doi.org/10.1056/nejmc1615918
  26. Mohammed S, Hussain S, Mirzoyev S, Edwards W, Maleszewski J, Redfield M. Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction. Circulation. 2015;131(6):550-559.  https://doi.org/10.1161/circulationaha.114.009625
  27. Germing A, Gotzmann M, Schikowski T, Vierkötter A, Ranft U, Krämer U, et al. High frequency of diastolic dysfunction in a population-based cohort of elderly women — but poor association with the symptom dyspnea. BMC Geriatr. 2011;11(1). https://doi.org/10.1186/1471-2318-11-71
  28. McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. https://doi.org/10.1093/eurheartj/ehab368
  29. Pieske B, Tschöpe C, de Boer R, Fraser A, Anker S, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: the HFA — PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297-3317. https://doi.org/10.1093/eurheartj/ehz641
  30. Gudieva K, Safarova A, Kobalava Z. Use of the HFA-PEFF algorithm for diagnosis of heart failure with preserved left ventricular ejection fraction. Clinical pharmacology and therapy. 2020;29(2):47-50. (In Russ.). https://doi.org/10.32756/0869-5490-2020-2-47-50
  31. Mareev YuV, Garganeeva AA, Tukish OV, Rebrova TYu, Anikina DV, Mareev VYu. Difficulties in diagnosis of heart failure with preserved ejection fraction in clinical practice: dissonance between echocardiography, NTproBNP and H2HFPEF score. Kardiologiia. 2020;59(12S):37-45. (In Russ.). https://doi.org/10.18087/cardio.n695
  32. Upadhya B, Kitzman D. Heart failure with preserved ejection fraction: New approaches to diagnosis and management. Clin Cardiol. 2019;43(2):145-155.  https://doi.org/10.1002/clc.23321
  33. Paulus W, Tschöpe C. A Novel Paradigm for Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2013;62(4):263-271.  https://doi.org/10.1016/j.jacc.2013.02.092
  34. Venteclef N, Guglielmi V, Balse E, Gaborit B, Cotillard A, Atassi F, et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. 2014;36(13):795-805.  https://doi.org/10.1093/eurheartj/eht099
  35. Obokata M, Reddy Y, Pislaru S, Melenovsky V, Borlaug B. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction. Circulation. 2017;136(1):6-19.  https://doi.org/10.1161/circulationaha.116.026807
  36. Kim S, Kim M, Shim W, Park S. Epicardial adipose tissue is related to cardiac function in elderly women, but not in men. Nutrition, Metabolism and Cardiovascular Diseases. 2017;27(1):41-47.  https://doi.org/10.1016/j.numecd.2016.11.001
  37. Kurnicka K, Domienik-Karłowicz J, Lichodziejewska B, Bielecki M, Kozłowska M, Goliszek S, et al. Improvement of left ventricular diastolic function and left heart morphology in young women with morbid obesity six months after bariatric surgery. Cardiol J. 2018;25(1):97-105.  https://doi.org/10.5603/cj.a2017.0059
  38. Kovacova Z, Tharp W, Liu D, Wei W, Xie H, Collins S, et al. Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes. Obesity. 2016;24(4):820-828.  https://doi.org/10.1002/oby.21418
  39. Mewton N, Opdahl A, Choi E, Almeida A, Kawel N, Wu C, et al. Left Ventricular Global Function Index by Magnetic Resonance Imaging — A Novel Marker for Assessment of Cardiac Performance for the Prediction of Cardiovascular Events. Hypertension. 2013;61(4):770-778.  https://doi.org/10.1161/hypertensionaha.111.198028
  40. Larina VN, Lunev VI, Alekhin MN. Left ventricular global function index: prognostic value in patients with heart failure aged 60 years and older. Cardiovascular Therapy and Prevention. 2020;19(5):2404. (In Russ.). https://doi.org/10.15829/1728-8800-2020-2404
  41. Thibodeau J, Turer A, Gualano S, Ayers C, Velez-Martinez M, Mishkin J, et al. Characterization of a Novel Symptom of Advanced Heart Failure: Bendopnea. JACC: Heart Failure. 2014;2(1):24-31.  https://doi.org/10.1016/j.jchf.2013.07.009
  42. Larina VN, Bart BYa, Chukaeva NI, Karpenko DG, Zacharova MI, Kulbachinskaya OM. Bendopnea: Association With Echocardiographic Features and Clinical Outcomes in Elderly Patients With Chronic Heart Failure. Kardiologiia. 2018;58(12):36-44. (In Russ.). https://doi.org/10.18087/cardio.2018.12.10190
  43. Kaya H, Şahin A, Güneş H, Bekar L, Çelik A, Çavuşoğlu Y., et al. Increased frequency of occurrence of bendopnea is associated with poor outcomes in heart failure outpatients. Acta Cardiol. 2020;76(8):878-886.  https://doi.org/10.1080/00015385.2020.1797303
  44. Knorre DG, Myzina SD. Biological Chemistry. M.: Higher School; 2000. (In Russ.).
  45. Berezov TT, Korovkin BF. Biological chemistry. M.: Medicine; 1998. (In Russ.).
  46. Vasyuk YuA, Kulikov KG, Kudryakov ON, Krikunova OV, Sadulaeva IA. Secondary mitochondrial dysfunction in acute coronary syndrome. Rational Pharmacotherapy in Cardiology. 2007;1:41-47. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.